Christophe Pardin

654 total citations
17 papers, 567 citations indexed

About

Christophe Pardin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Christophe Pardin has authored 17 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Organic Chemistry. Recurrent topics in Christophe Pardin's work include Blood properties and coagulation (8 papers), Ionic liquids properties and applications (3 papers) and Chemical Synthesis and Analysis (2 papers). Christophe Pardin is often cited by papers focused on Blood properties and coagulation (8 papers), Ionic liquids properties and applications (3 papers) and Chemical Synthesis and Analysis (2 papers). Christophe Pardin collaborates with scholars based in Canada, France and Ireland. Christophe Pardin's co-authors include Jeffrey W. Keillor, William D. Lubell, Joelle N. Pelletier, Isabelle Roy, Andreea R. Schmitzer, Juntao Luo, X. X. Zhu, Wolfgang Maison, Sylvie Fournel and Valeria Pavet and has published in prestigious journals such as Biochemistry, Cancer Research and Chemical Communications.

In The Last Decade

Christophe Pardin

17 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Pardin Canada 14 219 171 165 50 50 17 567
I. Le Trong United States 7 319 1.5× 106 0.6× 241 1.5× 26 0.5× 21 0.4× 7 844
Dominique Bridon United States 18 338 1.5× 352 2.1× 46 0.3× 40 0.8× 26 0.5× 29 966
Wanda Guedens Belgium 15 484 2.2× 70 0.4× 51 0.3× 32 0.6× 38 0.8× 34 812
Sushilla van Schoonhoven Austria 16 285 1.3× 110 0.6× 65 0.4× 23 0.5× 17 0.3× 23 556
Noriaki Tatsuta United States 12 426 1.9× 123 0.7× 66 0.4× 17 0.3× 16 0.3× 21 731
Federica Pisaneschi United States 16 255 1.2× 324 1.9× 43 0.3× 33 0.7× 17 0.3× 51 702
Eckhard Jähde Germany 12 414 1.9× 213 1.2× 52 0.3× 37 0.7× 25 0.5× 20 712
Venkatesh Chelvam India 21 339 1.5× 630 3.7× 127 0.8× 41 0.8× 27 0.5× 52 1.2k
Shaun D. Fontaine United States 14 397 1.8× 183 1.1× 70 0.4× 60 1.2× 10 0.2× 23 750
Gennady P. Samokhin Russia 17 483 2.2× 54 0.3× 141 0.9× 64 1.3× 31 0.6× 38 882

Countries citing papers authored by Christophe Pardin

Since Specialization
Citations

This map shows the geographic impact of Christophe Pardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Pardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Pardin more than expected).

Fields of papers citing papers by Christophe Pardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Pardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Pardin. The network helps show where Christophe Pardin may publish in the future.

Co-authorship network of co-authors of Christophe Pardin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Pardin. A scholar is included among the top collaborators of Christophe Pardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Pardin. Christophe Pardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Krishnan, Ramya, Andrew Macklin, Mohammed Selman, et al.. (2016). First-in-class small molecule potentiators of cancer virotherapy. Scientific Reports. 6(1). 26786–26786. 24 indexed citations
3.
Pardin, Christophe, et al.. (2015). Towards a characterization of the structural determinants of specificity in the macrocyclizing thioesterase for deoxyerythronolide B biosynthesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(3). 486–497. 18 indexed citations
4.
Pardin, Christophe, et al.. (2014). Site-specific protein labelling and immobilization mediated by microbial transglutaminase. Chemical Communications. 50(50). 6604–6606. 37 indexed citations
5.
Keillor, Jeffrey W., et al.. (2011). Irreversible Inhibitors of Tissue Transglutaminase. Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects. 78. 415–447. 18 indexed citations
6.
McGregor, Nicholas G. S., Christophe Pardin, & W. G. Skene. (2011). Using Quenching Kinetics and Thermodynamics of Amino-Fluorophores as Empirical Tools for Predicting Boronic Acid Sensors Suitable for Use in Physiological Conditions. Australian Journal of Chemistry. 64(11). 1438–1446. 6 indexed citations
7.
Pavet, Valeria, Julien Beyrath, Christophe Pardin, et al.. (2010). Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity. Cancer Research. 70(3). 1101–1110. 89 indexed citations
8.
Pardin, Christophe, et al.. (2010). Uncovering new properties of imidazolium salts: Cltransport and supramolecular regulation of their transmembrane activity. Chemical Communications. 47(6). 1788–1790. 38 indexed citations
9.
Pardin, Christophe, Loı̈c Leclercq, & Andreea R. Schmitzer. (2010). N,N′‐Methylenediimidazolium Salts: From Self‐Assembly to an Efficient DNAse Protection System. Chemistry - A European Journal. 16(15). 4686–4692. 19 indexed citations
10.
Pardin, Christophe, Isabelle Roy, Roberto A. Chica, et al.. (2009). Photolabeling of Tissue Transglutaminase Reveals the Binding Mode of Potent Cinnamoyl Inhibitors. Biochemistry. 48(15). 3346–3353. 20 indexed citations
11.
Pardin, Christophe, Isabelle Roy, William D. Lubell, & Jeffrey W. Keillor. (2008). Reversible and Competitive Cinnamoyl Triazole Inhibitors of Tissue Transglutaminase. Chemical Biology & Drug Design. 72(3). 189–196. 65 indexed citations
12.
Pardin, Christophe, Joelle N. Pelletier, William D. Lubell, & Jeffrey W. Keillor. (2008). Cinnamoyl Inhibitors of Tissue Transglutaminase. The Journal of Organic Chemistry. 73(15). 5766–5775. 82 indexed citations
13.
Keillor, Jeffrey W., Roberto A. Chica, Nicolas Chabot, et al.. (2008). The bioorganic chemistry of transglutaminase — from mechanism to inhibition and engineering. Canadian Journal of Chemistry. 86(4). 271–276. 40 indexed citations
14.
Luo, Juntao, Christophe Pardin, William D. Lubell, & X. X. Zhu. (2007). Poly(vinyl alcohol)-graft-poly(ethylene glycol) resins and their use in solid-phase synthesis and supported TEMPO catalysis. Chemical Communications. 2136–2136. 37 indexed citations
15.
Luo, Juntao, Christophe Pardin, X. X. Zhu, & William D. Lubell. (2007). Preparation, Characterization, and Application of Poly(vinyl alcohol)-graft-Poly(ethylene glycol) Resins:  Novel Polymer Matrices for Solid-Phase Synthesis. Journal of Combinatorial Chemistry. 9(4). 582–591. 11 indexed citations
16.
Pardin, Christophe, et al.. (2006). Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase. Bioorganic & Medicinal Chemistry. 14(24). 8379–8385. 31 indexed citations
17.
Brando, Thérèse, Christophe Pardin, Jacques Prandi, & Germain Puzo. (2002). Analysis of aminofluorescein–fatty acid derivatives by capillary electrophoresis with laser-induced fluorescence detection at the attomole level: application to mycobacterial fatty acids. Journal of Chromatography A. 973(1-2). 203–210. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026